Abstract
Purpose: This epidemiological retrospective survey aims to provide population-based estimates of the burden of hospitalisation for herpes zoster ophthalmicus in Spain during a twelve-year period (1997-2008). Methods: All hospital discharges and deaths related to herpes zoster ophthalmicus in patients older than 30 years old from 1997 to 2008 in Spain were obtained. Differences in proportions were assessed by the Chi-square test. ANOVA was used for multiple comparisons. Poisson regression was used to assess differences in the rates. Results: A total of 3029 hospital discharges in patients older than 30 years old were coded as herpes zoster ophthalmicus. Of those, 1009 were coded as primary cause of hospitalization. This corresponds to a hospitalization rate of 0.94 and 0.31 hospitalizations per 100,000 for any position and first diagnostic position, respectively. The 75% of the total discharges were in immunocompetent patients. The herpes zoster ophthalmicus hospitalization rate increased significantly during the study period. This increase was also observed for immunocompetent patients. A total of 127 and 21 deaths occurred in patients ≥ 30 year-old hospitalized with herpes zoster ophthalmicus in any diagnostic position and principal diagnostic code, respectively during the 12-year study period. Of them, 70 (53.4%) were in immunocompetent patients, and, of those 11 were in patients with HZO in the first diagnosis position. The hospitalization rate and case-fatality rate increase significantly with age from 50 years old onwards. Conclusion: HZO, a vaccine preventable disease, still causes hospitalization and death in adults in Spain.
Highlights
Herpes zoster ophtalmicus (HZO) occurs when the varicella zoster virus is reactivated in the ophthalmic division of the fifth cranial nerve
Hospital discharges related to herpes zoster ophthalmicus during the 12-year study period were studied
A total of 3339 hospital discharges were coded as herpes zoster ophthalmicus
Summary
Herpes zoster ophtalmicus (HZO) occurs when the varicella zoster virus is reactivated in the ophthalmic division of the fifth cranial nerve (trigeminal). Herpes zoster infection results from reactivation of varicella zoster virus which remains latent in sensory ganglia following varicella. In Europe, more than 95% of the adult population is VZV positive following varicella and at risk of HZ [3] It is estimated that 25 to 30% of the population and up to 50% of those living until 85 years of age [4] will suffer from herpes zoster (HZ) at least once in their lifetime [5]. [7] the incidence and severity of herpes zoster and postherpetic neuralgia increase with age due to the decrease of cell-mediated immunity to Varicella-Zoster Virus (VZV). Complications are associated with excess of morbidity, and are thought to be associated with an increase of the costs for the health care system
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.